Moody’s Acquires Praedicat, Adding Casualty and Liability Modeling Capabilities
Moody’s Corporation (NYSE:MCO) announced today that it has acquired Praedicat, a leading provider of casualty insurance analytics. The acquisition adds comprehensive casualty and liability modeling to Moody’s range of market leading solutions for the insurance industry, further enhancing its overall risk assessment strategy.
Praedicat’s models and predictive analytics help insurers and reinsurers navigate risks associated with catastrophic events, including product and environmental liabilities. Moody’s will integrate Praedicat’s capabilities into its existing suite of insurance solutions, providing casualty insurance industry customers with a holistic approach to understanding their risk exposure.
“As losses from catastrophic events are increasing, insurers are constantly looking for science-based casualty data and analytics,” said Rob Fauber, President and Chief Executive Officer of Moody’s. “Praedicat’s industry-leading liability modeling enhances our data and analytics capabilities to deliver actionable insights that will help the casualty insurance industry customers navigate the complex risk landscape.”
The transaction builds on Moody’s previous 2021 acquisition of RMS and advances Moody’s investments in new analytics and growth in the casualty market.
The terms of the transaction were not disclosed. The transaction will not have a material impact on Moody’s 2024 financial results.
For more information on casualty and financial lines underwriting, please click here.
ABOUT MOODY’S CORPORATION
In a world shaped by increasingly interconnected risks, Moody’s (NYSE: MCO) data, insights, and innovative technologies help customers develop a holistic view of their world and unlock opportunities. With a rich history of experience in global markets and a diverse workforce of approximately 15,000 across more than 40 countries, Moody’s gives customers the comprehensive perspective needed to act with confidence and thrive. Learn more at moodys.com.
“SAFE HARBOR” STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Certain statements contained in this release are forward-looking statements and are based on future expectations, plans and prospects for Moody’s business and operations that involve a number of risks and uncertainties. Such statements involve estimates, projections, goals, forecasts, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements. Stockholders and investors are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements and other information in this document are made as of the date hereof, and Moody’s undertakes no obligation (nor does it intend) to publicly supplement, update or revise such statements on a going-forward basis, whether as a result of subsequent developments, changed expectations or otherwise, except as required by applicable law or regulation. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Moody’s is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. These factors, risks and uncertainties include, but are not limited to: the impact of general economic conditions (including significant government debt and deficit levels, and inflation and related monetary policy actions by governments in response to inflation) on worldwide credit markets and on economic activity, including on the volume of mergers and acquisitions, and their effects on the volume of debt and other securities issued in domestic and/or global capital markets; the uncertain effectiveness and possible collateral consequences of U.S. and foreign government initiatives and monetary policy to respond to the current economic climate, including instability of financial institutions, credit quality concerns, and other potential impacts of volatility in financial and credit markets; the global impacts of the Russia - Ukraine military conflict and the military conflict in Israel and the surrounding areas on volatility in world financial markets, on general economic conditions and GDP in the U.S. and worldwide, on global relations and on the Company's own operations and personnel; other matters that could affect the volume of debt and other securities issued in domestic and/or global capital markets, including regulation, increased utilization of technologies that have the potential to intensify competition and accelerate disruption and disintermediation in the financial services industry, as well as the number of issuances of securities without ratings or securities which are rated or evaluated by non-traditional parties; the level of merger and acquisition activity in the U.S. and abroad; the uncertain effectiveness and possible collateral consequences of U.S. and foreign government actions affecting credit markets, international trade and economic policy, including those related to tariffs, tax agreements and trade barriers; the impact of MIS’s withdrawal of its credit ratings on countries or entities within countries and of Moody’s no longer conducting commercial operations in countries where political instability warrants such actions; concerns in the marketplace affecting our credibility or otherwise affecting market perceptions of the integrity or utility of independent credit agency ratings; the introduction or development of competing and/or emerging technologies and products; pricing pressure from competitors and/or customers; the level of success of new product development and global expansion; the impact of regulation as an NRSRO, the potential for new U.S., state and local legislation and regulations; the potential for increased competition and regulation in the jurisdictions in which we operate, including the EU; exposure to litigation related to our rating opinions, as well as any other litigation, government and regulatory proceedings, investigations and inquiries to which Moody’s may be subject from time to time; provisions in U.S. legislation modifying the pleading standards and EU regulations modifying the liability standards applicable to credit rating agencies in a manner adverse to credit rating agencies; provisions of EU regulations imposing additional procedural and substantive requirements on the pricing of services and the expansion of supervisory remit to include non-EU ratings used for regulatory purposes; uncertainty regarding the future relationship between the U.S. and China; the possible loss of key employees and the impact of the global labor environment; failures or malfunctions of our operations and infrastructure; any vulnerabilities to cyber threats or other cybersecurity concerns; the timing and effectiveness of any restructuring programs; currency and foreign exchange volatility; the outcome of any review by tax authorities of Moody’s global tax planning initiatives; exposure to potential criminal sanctions or civil remedies if Moody’s fails to comply with foreign and U.S. laws and regulations that are applicable in the jurisdictions in which Moody’s operates, including data protection and privacy laws, sanctions laws, anti-corruption laws, and local laws prohibiting corrupt payments to government officials; the impact of mergers, acquisitions, such as our acquisition of RMS, or other business combinations and the ability of Moody’s to successfully integrate acquired businesses; the level of future cash flows; the levels of capital investments; and a decline in the demand for credit risk management tools by financial institutions. These factors, risks and uncertainties as well as other risks and uncertainties that could cause Moody’s actual results to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements are described in greater detail under “Risk Factors” in Part I, Item 1A of Moody’s annual report on Form 10-K for the year ended December 31, 2023, and in other filings made by the Company from time to time with the SEC or in materials incorporated herein or therein. Stockholders and investors are cautioned that the occurrence of any of these factors, risks and uncertainties may cause the Company’s actual results to differ materially from those contemplated, expressed, projected, anticipated or implied in the forward-looking statements, which could have a material and adverse effect on the Company’s business, results of operations and financial condition. New factors may emerge from time to time, and it is not possible for the Company to predict new factors, nor can the Company assess the potential effect of any new factors on it. Forward-looking and other statements in this document may also address our corporate responsibility progress, plans, and goals (including sustainability and environmental matters), and the inclusion of such statements is not an indication that these contents are necessarily material to investors or required to be disclosed in the Company’s filings with the Securities and Exchange Commission. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905321224/en/
Contacts
For Moody’s Investor Relations:
Shivani Kak
Moody’s Corporation
+1 212-553-0298
Shivani.Kak@moodys.com
For Moody’s Communications:
Chris Cashman
Moody’s Corporation
Chris.Cashman@moodys.com
+1 212-553-1461
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gcore Introduces AI-Driven Web Application and API Protection at the Edge17.9.2024 10:00:00 CEST | Press release
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced the launch of Gcore WAAP, its end-to-end web application and API protection solution. Leveraging advanced AI capabilities, Gcore WAAP integrates four powerful products in one solution: web application firewall (WAF), application-layer DDoS protection, bot management, and API security, all managed through an intuitive user interface. This comprehensive, multi-layered security solution protects digital assets across a wide range of verticals, including retail, financial services, healthcare, public sector, media and entertainment, and technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917971916/en/ Gcore WAAP delivers comprehensive web application and API protection against a broad range of advanced threats (Graphic: Business Wire) Gcore WAAP was developed following the company’s acquisition of the StackPath WAAP solution ear
Enzian Pharmaceutics Develops a Novel Dosage Form for Enhanced Efficacy and Reduced Side Effects of Cancer Therapies17.9.2024 09:21:00 CEST | Press release
At present, the prevalent oral solid dosage forms, the capsules and tablets, are loose or lightly compacted mixtures of drug and excipient particles. Upon ingestion, they rapidly disintegrate into their constituents in the stomach. The small drug particles then are swept out of the stomach and pass through the intestine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917927016/en/ Dr. Aron Blaesi, inventor of expandable, gastroretentive fibrous dosage forms presenting dosage forms before and after expansion due to water absorption. (Photo: Business Wire) Many kinds of cancer drug, however, are absorbed only in the acidic upper part of the gastrointestinal tract. Because the gastric residence time of the drug particles (~2-3 hours) is much shorter than the convenient dosing interval (~12-24 hours), upon repeated dosing of such drugs the drug concentration in blood fluctuates greatly. This is therapeutically not optimal: Th
Alter Domus Announces Outsourcing Partnership with Partners Group17.9.2024 09:00:00 CEST | Press release
Alter Domus, a leading provider of tech-enabled fund administration, asset and corporate services for the alternative investment industry, has entered an outsourcing partnership with Partners Group, one of the largest firms in the global private markets industry. The partnership sees Alter Domus support a broad range of operational functions for Partners Group's closed-end product offerings, spanning investment structures across the U.S., Europe and Asia. Alter Domus was selected by Partners Group for its service delivery, breadth of technology capabilities, global footprint, and the distinctiveness of its tried-and-tested approach, focused on ‘co-creating’ bespoke operating models tailored to meet the specific priorities of individual investment managers. The partnership, which went live on June 1, commits Alter Domus to invest in innovation and integration to deliver a high level of service quality and enhanced efficiency across Partners Group’s operations. Other factors include join
CSG and Cellusys Drive New Era of Innovation in Roaming17.9.2024 08:30:00 CEST | Press release
Mobile operators face growing challenges in managing complex roaming agreements, settlements and network quality, impacting their customer experience and business growth. Today,CSG® (NASDAQ: CSGS) announced a new partnership with Cellusys, the industry leader in roaming steering, fraud and security and analytics solutions for mobile operators, that will address these pain points and boost innovation in the global roaming landscape. “In any rapidly evolving industry, businesses need best-of-breed solutions that can promote their growth to stay ahead of the curve,” said Finn Kornbo, Executive Product Director, Digital Wholesale, CSG. “That's why we're partnering with Cellusys to combine our expertise and make it easy for mobile operators to optimize their roaming workflows, improve customer satisfaction and capitalize on emerging technologies like 5G and IoT.” This partnership leverages the strengths of both CSG and Cellusys to deliver a unified solution portfolio that streamlines the ro
MDPI Elevates Peer Review with AI and Innovative Technology17.9.2024 08:00:00 CEST | Press release
MDPI, a leading open access (OA) publisher, is pleased to announce its participation in Peer Review Week 2024, taking place 23–27 September. This year’s theme, “Innovation and Technology in Peer Review”, explores the evolving publishing landscape and how peer review processes shape scholarly communication. Over the week, MDPI will host online webinars from both Europe and Asia-Pacific, deliver in-person events in China, and publish new blog articles, engaging authors, reviewers, editors, and the global scientific community in the future of research integrity. Webinar: Roundtable Discussion on Innovation and Technology in Peer Review Join us as our panellists share their experiences and insights into the future of publishing, and the essential role of peer review—24 September 2024, 03:00 pm (CEST). MDPI Tools: Innovating Peer Review At MDPI, we actively pursue innovative technologies to ensure high-quality manuscripts are published in our journals. Ethicality, currently in testing,will
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom